No benefit of plasma therapy arresting mortality in moderate to severe Covid-19 cases: ICMR

Addressing a press conference here Bhargava said, "An ICMR study has clearly established no benefit of plasma therapy in arresting mortality in moderate to severe cases of Covid-19. Following a cue from it, we have developed horse serum, for which we have got clearance for clinical trial."